Sanders Seeks Investigation of NIH Licensing Practices

The senator wants the inspector general to probe why the NIH licensed a potentially lucrative cancer drug to an obscure company linked to a former employee.


You can count on the Prospect, can we count on you?

There's no paywall here. Your donations power our newsroom as we report on ideas, politics and power — and what’s really at stake as we navigate another presidential election year. Please, become a member, or make a one-time donation, today. Thank you!